Abstract

Research into the molecular basis of disease trajectory and Long-COVID is important to get insights toward underlying pathophysiological processes. The objective of this study was to investigate inflammation-mediated changes of metabolism in patients with acute COVID-19 infection and throughout a one-year follow up period. The study enrolled 34 patients with moderate to severe COVID-19 infection admitted to the University Clinic of Innsbruck in early 2020. The dynamics of multiple laboratory parameters (including inflammatory markers [C-reactive protein (CRP), interleukin-6 (IL-6), neopterin] as well as amino acids [tryptophan (Trp), phenylalanine (Phe) and tyrosine (Tyr)], and parameters of iron and vitamin B metabolism) was related to disease severity and patients’ physical performance. Also, symptom load during acute illness and at approximately 60 days (FU1), and one year after symptom onset (FU2) were monitored and related with changes of the investigated laboratory parameters: During acute infection many investigated laboratory parameters were elevated (e.g., inflammatory markers, ferritin, kynurenine, phenylalanine) and enhanced tryptophan catabolism and phenylalanine accumulation were found. At FU2 nearly all laboratory markers had declined back to reference ranges. However, kynurenine/tryptophan ratio (Kyn/Trp) and the phenylalanine/tyrosine ratio (Phe/Tyr) were still exceeding the 95th percentile of healthy controls in about two thirds of our cohort at FU2. Lower tryptophan concentrations were associated with B vitamin availability (during acute infection and at FU1), patients with lower vitamin B12 levels at FU1 had a prolonged and more severe impairment of their physical functioning ability. Patients who had fully recovered (ECOG 0) presented with higher concentrations of iron parameters (ferritin, hepcidin, transferrin) and amino acids (phenylalanine, tyrosine) at FU2 compared to patients with restricted ability to work. Persistent symptoms at FU2 were tendentially associated with IFN-γ related parameters. Women were affected by long-term symptoms more frequently. Conclusively, inflammation-mediated biochemical changes appear to be related to symptoms of patients with acute and Long Covid.

Details

Title
Laboratory parameters related to disease severity and physical performance after reconvalescence of acute COVID-19 infection
Author
Gietl, Mario 1 ; Burkert, Francesco 1 ; Hofer, Stefanie 2 ; Gostner, Johanna M. 2 ; Sonnweber, Thomas 1 ; Tancevski, Ivan 1 ; Pizzini, Alex 1 ; Sahanic, Sabina 1 ; Schroll, Andrea 1 ; Brigo, Natascha 1 ; Egger, Alexander 3 ; Bellmann-Weiler, Rosa 1 ; Löffler-Ragg, Judith 1 ; Weiss, Günter 1 ; Kurz, Katharina 1 

 Medical University of Innsbruck, Department of Internal Medicine II, Innsbruck, Austria (GRID:grid.5361.1) (ISNI:0000 0000 8853 2677) 
 Medical University of Innsbruck, Institute of Medical Biochemistry, Biocenter, Innsbruck, Austria (GRID:grid.5361.1) (ISNI:0000 0000 8853 2677) 
 Tirol Kliniken GmbH, Central Institute for Medical and Chemical Laboratory Diagnostics (ZIMCL), Innsbruck, Austria (GRID:grid.452055.3) (ISNI:0000000088571457) 
Pages
10388
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3051220888
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.